Am I dependent on a lifetime use of antipsychotics? A qualitative analysis of Q&A data about stopping and tapering antipsychotics from the perspective of users and their relatives

Background: Many antipsychotic users at some point want to stop their antipsychotic. They mention side effects, functioning, experiencing no benefits and health concerns as motivations. The aim was to explore questions antipsychotic users and their relatives have about stopping or tapering antipsychotics. Methods: Data were used from a publicly available anonymous expert Q&A in which experts answered questions about mental health. Questions about stopping or tapering antipsychotics asked by antipsychotics users and their relatives were analysed using an inductive content analysis. Results: A total of 3000 questions were screened, where 426 were about antipsychotics and 194 were about stopping or tapering antipsychotics. The most common question was whether it was sensible to stop. Questions focused on how fast to taper, what their minimum dose should be, where to find support and when withdrawal symptoms or side effects would subside. Motivations were side effects, difficulties in functioning and experiencing no benefits. Barriers were lack of support and return of symptoms. Facilitators were support and experiencing a relief from side effects and/or symptoms. Discussion: Antipsychotic users and their relatives are left with many questions about tapering antipsychotics. These questions reveal attitudes, preferences and concerns that are important to address when discussing antipsychotic treatment.

Authors

Institutions

Publication Details

Journal
Psychosis
Published
2024-12-19
DOI
https://doi.org/10.1080/17522439.2024.2430466
Citations
1
Primary Topic
Schizophrenia research and treatment
Type
article
Field-Weighted Citation Impact
0.39
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Am I dependent on a lifetime use of antipsychotics? A qualitative analysis of Q&A data about stopping and tapering antipsychotics from the perspective of users and their relatives

Jim van Os, Stijn Crutzen, Stynke Castelein
1 citations
Psychosis
Schizophrenia research and treatment
0.39
article

Am I dependent on a lifetime use of antipsychotics? A qualitative analysis of Q&A data about stopping and tapering antipsychotics from the perspective of users and their relatives

Jim van Os, Stijn Crutzen, Stynke Castelein
article en
1 citations

Abstract

Background: Many antipsychotic users at some point want to stop their antipsychotic. They mention side effects, functioning, experiencing no benefits and health concerns as motivations. The aim was to explore questions antipsychotic users and their relatives have about stopping or tapering antipsychotics. Methods: Data were used from a publicly available anonymous expert Q&A in which experts answered questions about mental health. Questions about stopping or tapering antipsychotics asked by antipsychotics users and their relatives were analysed using an inductive content analysis. Results: A total of 3000 questions were screened, where 426 were about antipsychotics and 194 were about stopping or tapering antipsychotics. The most common question was whether it was sensible to stop. Questions focused on how fast to taper, what their minimum dose should be, where to find support and when withdrawal symptoms or side effects would subside. Motivations were side effects, difficulties in functioning and experiencing no benefits. Barriers were lack of support and return of symptoms. Facilitators were support and experiencing a relief from side effects and/or symptoms. Discussion: Antipsychotic users and their relatives are left with many questions about tapering antipsychotics. These questions reveal attitudes, preferences and concerns that are important to address when discussing antipsychotic treatment.

PsychosisVol. 17(3)
University of Groningen (NL), King's College London (GB), Maastricht University Medical Centre (NL), University Medical Center Utrecht (NL), Lentis (NL), Kings Health Partners (GB)
Gender equality
Openalex Percentile: Top 32%
Schizophrenia research and treatment
0.39
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.